Labcorp Clinical Trials is a business segment of Labcorp Inc., a leading global life sciences company, which provides contract research services to the drug, medical device and diagnostics, crop protection and chemical industries. Labcorp is a registered trademark and the marketing name for Labcorp Inc. and its subsidiaries around the world.
Screening Appointments Available Now!
8500-729 3 3
Back To Current StudiesScreening Appointments Available Now!
Study Number
8500-729 3Group
3Gender
bothAge
20 - 70Location
Daytona Beach, FloridaCompensation
$11,453Study Dates
Feb. 18 - May 01, 2023Additional Information
The investigational drug in this research study is being developed for the potential treatment of patients with obesity or type 2 diabetes. The purpose of this study is to evaluate safety, tolerability, how much of the study drug gets into the bloodstream and how long the body takes to get rid of it following multiple doses in combination with tirzepatide. Tirzepatide is a medication intended to help control blood sugar levels in patients with type 2 diabetes. In addition, body weight, appetite, waist and hip circumference, and the amount of time it takes for substances to move through the stomach (stomach emptying) will be evaluated.
Labcorp Daytona Beach is recruiting for:
- Healthy Men and Women of Non-childbearing potential, age 20-70
- Body Mass Index between 27-45
- Study involves 3 separate stays totaling 9 nights, 4 out-patient visits & 1 phone call
- Compensation up to $11,453 may be provided for time and participation
- Receive up to $300 per qualified participant
Details
Call Now to Schedule Your Screening Appointment!
Check-in: Feb 18
Check-out: Feb 22
Follow up Visit: Feb 27
Phone Call: Mar 1
Check-in: Mar 5
Check-out: Mar 8
Follow up Visit: Mar 13
Check-in: Mar 19
Check-out: Mar 21
Follow up Visits: Apr 3 & May 1